advertisement
Reply
 
Thread Tools Display Modes
Old 12-02-2010, 08:10 PM #1
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
NewsBot NewsBot is offline
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 65,355
15 yr Member
Post TreatmentTrends , Multiple Sclerosis Study Uncovers Early Impact Of Gilenya

BioTrends recently published TreatmentTrends: Multiple Sclerosis, a syndicated biannual report that provides a comprehensive view of the current and expected future management of multiple sclerosis based on primary research fielded with 103 neurologists in the U.S. A parallel report covering the European market will be published later this month.



More...

(From Topix Neurology)
NewsBot is offline   Reply With QuoteReply With Quote

advertisement
Old 12-03-2010, 04:25 AM #2
TheSleeper's Avatar
TheSleeper TheSleeper is offline
Member
 
Join Date: Jan 2008
Location: About 35 miles southwest of Cleveland Ohio
Posts: 499
15 yr Member
TheSleeper TheSleeper is offline
Member
TheSleeper's Avatar
 
Join Date: Jan 2008
Location: About 35 miles southwest of Cleveland Ohio
Posts: 499
15 yr Member
Default

"Gilenya treats the relapsing form of MS. The drug significantly reduces MS attacks. However, it has serious side effects, with possible heart, lung, and eye toxicity and increased risk of infection. Patients must be closely monitored, and regular eye exams are advised."
__________________
ditched the witch
.
TheSleeper is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Dejibo (12-03-2010), dmplaura (12-03-2010), Kitty (12-05-2010), SallyC (12-03-2010)
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Multiple Sclerosis: New MRI Contrast Medium Enables Early Diagnosis In Animal Model ( NewsBot Multiple Sclerosis 8 08-07-2008 11:49 AM
NEJM: Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study fmichael Multiple Sclerosis 1 07-29-2007 03:39 PM


All times are GMT -5. The time now is 03:37 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.